Efficient Collaboration Earns High Praise: RayThera Honors Medicilon with “Excellent Partnership Award”

Preclinical CRO

On November 10, Dr. Gene Hung, Founder and Chief Scientific Officer of RayThera, Inc., visited Medicilon’s Nanhui campus to further strengthen strategic collaboration and recognize outstanding achievements. During the visit, RayThera presented Medicilon with the “Excellent Partnership Award”, the Chemistry FTE Team with the “Excellent Service Team Award”, and Dr. Zhu Du, Vice President of […]

Search Medicilon

Preclinical CRO

World’s First Phase III Positive B7-H3 ADC: Medicilon Congratulates MediLink Therapeutics on NDA Acceptance of Icontamrotamab

Preclinical CRO

Medicilon Webinar | IND-enabling Toxicity Studies, CTD Documentation and Translational Cardiac Risk Assessment

Preclinical CRO

Medicilon Stands Out at ASMS 2026: Only CRO Selected for Bioanalysis Zone’s ‘Pick of the Posters’

Contact Medicilon

Name(Required)
Address(Required)